ISABEL C ROJAS SANTAMARIA

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology DALLAS, TX NPI 1548307481

General Payments — all program years on this page

$1,217.21

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 41
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $364.82 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $364.8213

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $207.188
2019 $367.349
2020 $13.111
2021 $195.566
2022 $16.151
2023 $53.053
2024 $364.8213

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1114148689 Regeneron Healthcare Solutions, Inc. $21.12 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123322615 Mirum Pharmaceuticals, Inc. $20.07 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123428488 Alcresta Therapeutics, Inc. $25.41 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137663876 Takeda Pharmaceuticals U.S.A., Inc. $28.45 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137663878 Takeda Pharmaceuticals U.S.A., Inc. $16.63 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137663880 Takeda Pharmaceuticals U.S.A., Inc. $26.17 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140010880 GENZYME CORPORATION $29.57 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140010954 GENZYME CORPORATION $36.17 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140010956 GENZYME CORPORATION $30.85 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140010968 GENZYME CORPORATION $32.49 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140010972 GENZYME CORPORATION $32.50 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140010980 GENZYME CORPORATION $30.79 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140010986 GENZYME CORPORATION $34.60 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.